000 01162 a2200289 4500
005 20250517110501.0
264 0 _c20170327
008 201703s 0 0 eng d
022 _a1349-2896
024 7 _a10.2183/pjab.92.222
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKanai, Yoshiyuki
245 0 0 _aOverview on poly(ADP-ribose) immuno-biomedicine and future prospects.
_h[electronic resource]
260 _bProceedings of the Japan Academy. Series B, Physical and biological sciences
_c2016
300 _a222-36 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies
_ximmunology
650 0 4 _aHistones
_ximmunology
650 0 4 _aHumans
650 0 4 _aLupus Erythematosus, Systemic
_xblood
650 0 4 _aNerve Degeneration
_xdrug therapy
650 0 4 _aPoly Adenosine Diphosphate Ribose
_xchemistry
650 0 4 _aPoly(ADP-ribose) Polymerase Inhibitors
_xpharmacology
773 0 _tProceedings of the Japan Academy. Series B, Physical and biological sciences
_gvol. 92
_gno. 7
_gp. 222-36
856 4 0 _uhttps://doi.org/10.2183/pjab.92.222
_zAvailable from publisher's website
999 _c26283958
_d26283958